Back to news

TRAC led the automation of mRNA vaccine production

TRAC led the automation of mRNA vaccine production

TRAC is specialized in highly demanding technological processes in the field of control and automation of production processes in the pharmaceutical industry and was recognized by the Swiss company LONZA AG which invited TRAC to participate in the automation of MODERNA’s Covid-19 mRNA vaccine. TRAC took over the complete automation project management of the three vaccine production lines in July 2020. The project was very time critical and subject to high expectations from a global population. On the other hand, it was a new challenge for TRAC to show how we put our principle – Do it once, Do it right – into practice.

The project was successfully completed in early 2021 when regular production of the mRNA vaccine for Covid-19 started. TRAC received a special award from Lonza for our outstanding contribution to delivering a high quality vaccine based on mRNA technology.

At TRAC, we are proud of every successful project we complete, but we are especially proud when we can contribute to pandemic control and work for the benefit of public health.